论文部分内容阅读
目的:观察和分析硝苯地平控释片联合厄贝沙坦片治疗原发性高血压患者的临床效果。方法:选择我院及青海省人民医院2014年1月—2015年4月收治的110例原发性高血压Ⅱ级以上患者,将其随机分为治疗组55例与对照组55例,治疗组患者采用硝苯地平控释片联合厄贝沙坦治疗,对照组采用硝苯地平片联合卡托普利片治疗,观察两组患者经过临床治疗后的血压达标率。结果:治疗组患者的临床血压达标率明显优于对照组患者(P<0.05),具有统计学意义。结论:硝苯地平控释片联合厄贝沙坦片在原发性高血压患者临床治疗中的效果显著,在我国的原发性高血压临床治疗中值得推广和应用。
Objective: To observe and analyze the clinical effect of nifedipine controlled release tablets combined with irbesartan tablets in patients with essential hypertension. Methods: A total of 110 patients with grade Ⅱ or higher primary hypertension admitted from our hospital and Qinghai People’s Hospital from January 2014 to April 2015 were randomly divided into treatment group (55 cases) and control group (55 cases), treatment group The patients were treated with nifedipine controlled release tablets combined with irbesartan, the control group with nifedipine tablets combined with captopril tablets, and the compliance rate of blood pressure after the clinical treatment was observed in both groups. Results: The clinical blood pressure compliance rate of the treatment group was significantly better than that of the control group (P <0.05), with statistical significance. Conclusion: Nifedipine GITS and irbesartan tablets are effective in the treatment of patients with essential hypertension. It is worthy of promotion and application in the clinical treatment of essential hypertension in our country.